In this episode, Henry Bell discussed the future of cardiology in Latin America. He was joined by Luis Fonseca, the General Manager for Canada and Latin America at Inari Medical.
In this episode, Henry Bell discussed the future of cardiology in Latin America. He was joined by Luis Fonseca, the General Manager for Canada and Latin America at Inari Medical.
In this episode, Henry Bell discussed the future of cardiology in Latin America. He was joined by Luis Fonseca, the General Manager for Canada and Latin America at Inari Medical.
.jpg)
With the limited data we have so far, PFA has proven to be safer than other ablation energies and to provide quicker recovery times. But is it ready to revolutionise cardiac ablations? To find out, I spoke to five leaders from start-ups in the space.
.jpg)
I caught up with the Managing Director, Steven Haken, and Director, Deboarah Rizzi, of Odelle Technology, to discuss the importance of market access and how it works.
I caught up with Kris Holland, Director of Marketing and Communications at Charlton Morris, to discuss the importance of timing when making a new hire to help take a medical device to market.
I caught up with the Managing Director, Steven Haken, and Director, Deboarah Rizzi, of Odelle Technology, to gain insight into why data is so crucial to market access.
In this episode, I'm joined by Steven Haken and Deborah Rizzi from market access and reimbursement specialists Odelle Technology to discuss how to take a medical device to market.
I caught up with the Head of Digital Health, Diagnostics & Monitoring at Biotronik, Ken Nelson, to talk about the increasing value of data within the space.
.jpg)
I caught up with the Head of Digital Health, Diagnostics & Monitoring at Biotronik, Ken Nelson, to talk about the company culture at Biotronik.
.jpg)
I caught up with the Head of Digital Health, Diagnostics & Monitoring at Biotronik, Ken Nelson, to talk about Biotronik's developments during the COVID-19 pandemic.
This CM Conversations episode is all about cardiac digital health and data. To take on the topic, I was joined by Ken Nelson who's the Head of Digital Health, Diagnostics, & Monitoring at Biotronik.
There’s optimism throughout all the med-tech markets we serve and to celebrate this we asked our CM Medical recruitment specialists about innovations, industry news and trends to expect from the year ahead.
.jpg)
Diagnosis of heart failure must be rapid and accurate. However, that can be a challenge for doctors without the right information and data.
With opportunity rife all over the world, I wanted to share some of the most exciting growth happening within contract manufacturing for medical devices. Here’s five companies that everyone should be getting excited about.
For this episode of CM Conversations, Ben Thompson & Jerome Richards, Directors at CM Medical, spoke with Rob Jenkins and Will Flack from F&J Agile Solutions.
It’s only now, that a handful of pioneering start-ups have emerged with Transcatheter Tricuspid Valve Repair/Replacement (TTVR) devices to offer an alternative to surgery. I spoke to some of these companies' leading experts.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting.
As businesses prioritise the wellbeing of their employees, the concept of working a 4 day week is shifting from distant pipedream to reality for a range of organisations around the world.
The structural heart space is one of the most exciting areas in the whole of medical devices. A broad term, covering a range of cardiac conditions, the advances in technology over the last 20 years has been extremely impressive, with no sign of slowi
Fresh approaches to AI, mixed reality, surgical robotics and CCM are changing the way we think about cardiology.
.png)
I headed down to London to meet Circle's VP of Marketing, Daniel Leite, and learn more about their technology, the future of the medical imaging market and life at Circle.
From talking to experts in my network, many have pointed out a rising misconception. Some individuals among of the healthcare community believe that we’ve reached the ‘best we can get’ with CRM devices.
Cardiovascular disease is the number one cause of death globally, accounting for 17.9 million mortalities each year. To battle these ugly death-toll statistics, more companies are emerging with innovative, life-saving treatments across the globe.
Artificial Intelligence is a new technology and, for the most part, one of its biggest challenges is just working out how it will be applied. Where it can be used best, most cost-effectively and easiest to gain the best results.
The ‘implant files’ have been published. Following research conducted by over 250 journalists from 59 media organisations across 36 countries, reports of ‘adverse incidents’ stemming from implanted medical devices have hit the headlines.
It’s not often that med tech makes front page news, but it has today - with Apple’s announcement yesterday that they’re including an FDA approved ECG scanner in the Series 4, their latest smartwatch.
The Cardiac Transcatheter Valve business, particularly TAVI, is an area that has been causing disruption in the cardiovascular industry for years - slowly eating away at the Surgical Valve space.
